StockNews.com Initiates Coverage on ContraFect (NASDAQ:CFRX)

StockNews.com assumed coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report published on Sunday. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Price Performance Shares of ContraFect stock opened at $0.05 on Friday. The firm has a market cap of $535,000.00, a price-to-earnings ratio of 0.00 and a […]

Leave a Reply

Your email address will not be published.

Previous post AstroNova (NASDAQ:ALOT) Research Coverage Started at StockNews.com
Next post Switzerland Full Year 2023: Tesla Model Y repeats at #1 followed by Skoda Enyaq